Lisinopril improves arterial function in hyperlipidaemia

Clinical Science

Volumn 96, Issue 5, 1999, Pages 441-448

  Lee, Alison F C ^a   Dick, John B C ^a   Bonnar, Clare E ^a   Struthers, Allan D ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Angiotensin converting enzyme; Arterial function; Endothelium; Hyperlipidaemia; Lisinopril

Indexed keywords

ACETYLCHOLINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LISINOPRIL; NITROPRUSSIDE SODIUM; VASODILATOR AGENT;

ADULT; ARTERY ENDOTHELIUM; ARTERY INJURY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; FOREARM BLOOD FLOW; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REGRESSION ANALYSIS; SYSTOLIC BLOOD PRESSURE; VASODILATATION; VEIN OCCLUSION PLETHYSMOGRAPHY;

ACETYLCHOLINE; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ARTERIES; DOUBLE-BLIND METHOD; ENDOTHELIUM, VASCULAR; FEMALE; FOREARM; HUMANS; HYPERLIPIDEMIAS; LISINOPRIL; MALE; MIDDLE AGED; NITROPRUSSIDE; PLETHYSMOGRAPHY; VASODILATOR AGENTS;

EID: 0032935718     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS19980386     Document Type: Article

References (47)

1. 1 Martin, M. J., Hulley, S. B., Browner, W. S., Kuller, L. H. and Wentworth, D. (1986) Serum cholesterol, blood pressure, and mortality: implications from a cohort of 361,662 men. Lancet 2, 933-936
2. 2 Vita, J. A., Treasure, C. B., Nabel, E. G. et al. (1990) Coronary vasomotor responses to acetylcholine relates to risk factors for coronary artery disease. Circulation 81, 491-497
3. 3 Chowienczyk, P. J., Watts, G. F., Cockcroft, J. R. and Ritter, J. M. (1992) Impaired endothelium-dependent vasodilation of forearm resistance vessels in hypercholesterolaemia. Lancet 340, 1430-1432
4. 4 Anderson, T. J., Uehata, A., Gerhard, M. D. et al. (1995) Close relation of endothelial function in the human coronary and peripheral circulations. J. Am. Coll. Cardiol. 26, 1235-1241
5. 5 Vogel, R. A., Vaitkevicius, P. W. and Plotnick, G. D. (1993) Ultrasound assessment of brachial artery endothelium-dependent vasoactivity as a means for diagnosing coronary artery disease. J. Am. Coll. Cardiol. 21, 345A (Abstract)
6. 6 Heitzer, T., Yla-Herttuala, S., Luoma, J. et al. (1996) Cigarette smoking potentiates endothelial dysfunction of forearm resistance vessels in patients with hypercholesterolemia. Circulation 93, 1346-1353
7. 7 Scandinavian Simvastatin Survival Group. (1994) Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 344, 1383-1389
8. 8 Treasure, C. B., Klein, J. L., Weintraub, W. S. et al. (1995) Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease. N. Engl. J. Med. 332, 481-487
9. 9 Rutherford, J. D., Pfeffer, M. A., Moye, L. A. et al. (1994) Effects of captopril on ischaemic events after myocardial infarction. Circulation 90, 1731-1738
10. 10 Nakamura, M., Funakoshi, T., Arakawa, N., Yoshida, H., Makita, S. and Hiramori, K. (1994) Effect of angiotensin-converting enzyme inhibitors on endothelium-dependent peripheral vasodilatation in patients with chronic heart failure. J. Am. Coll. Cardiol. 24, 1321-1327
11. 11 Mancini, G. B., Henry, G. C., Macaya, C. et al. (1996) Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing Endothelial Dysfunction) Study. Circulation 94, 258-265
12. 12 Bijlstra, P. J., Smits, P., Lutterman, A. and Thien, T. (1995) Effect of long-term angiotensin-converting enzyme inhibition on endothelial function in patients with the insulin-resistance syndrome. J. Cardiovasc. Pharmacol. 25, 658-664
13. 13 Chobanian, A. V., Haudenschild, C. C., Nickerson, C. and Drago, R. (1990) Antiatherogenic effect of captopril in the Watanabe heritable hyperlipidemic rabbit. Hypertension 15, 327-331
14. 14 Lichtenstein, A. H., Drago, R., Nickerson, C., Prescott, M. F., Lee, S. Q. and Chobanian, A. V. (1989) The effect of propranolol on atherogenesis in the Watanabe heritable hyperlipidaemic rabbit. J. Vasc. Med. Biol. 1, 248-254
15. 15 Tilton, G. D., Bujam L. M., Bilheimerm D. W. et al. (1985) Failure of a slow channel calcium antagonist, verapamil, to retard atherosclerosis in the Watanabe heritable hyperlipidemic rabbit: an animal model of familial hypercholesterolemia. J. Am. Coll. Cardiol. 6, 141-144
16. 16 Griendling, K. K., Minieri, C. A., Ollerenshaw, J. D. and Alexander, R. W. (1994) Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ. Res. 74, 1141-1148
17. 17 Rajagopalan, S., Kurtz, S., Munzel, T. et al. (1996) Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J. Clin. Invest. 97, 1916-1923
18. 18 Parthasarathy, S., Steinberg, D. and Witztum, J. L. (1992) The role of oxidized low-density lipoproteins in the pathogenesis of atherosclerosis. Annu. Rev. Med. 43, 219-225
19. 19 Diet, F. P., Dzau, V. J. and Pratt, R. E. (1994) ACE is expressed by macrophages found in human coronary atherosclerotic plaques. Circulation 90, 1572 (Abstract)
20. 20 Aberg, G. and Ferrer, P. (1990) Effects of captopril on atherosclerosis in cynomolgus monkeys. J. Cardiovasc. Pharmacol. 15, S56-S72
21. 21 Becker, R. H. A., Wiemer, G. and Linz, W. (1991) Preservation of endothelial function by ramipril in rabbits on a long-term atherogenic diet. J. Cardiovasc. Pharmacol. 18, S110-S115
22. 22 Benjamin, N., Calver, A., Collier, J., Robinson, B., Vallance, P. and Webb, D. (1995) Measuring forearm blood flow and interpreting the responses to drugs and mediators. Hypertension 25, 918-923
23. 23 Chowienczyk, P. J., Cockcroft, J. R. and Ritter, J. M. (1994) Blood flow responses to intra-arterial acetylcholine in man: effects of basal flow and conduit vessel length. Clin. Sci. 87, 45-51
24. 24 Durrington, P. N. (1989) Classification of hyperlipoproteinaemia. In Hyperlipidemia, Diagnosis and Management, Wright Borough Green, Sevenoaks, Kent
25. 25 Anderson, T. J., Meredith, I. T., Yeung, A. C., Frei, B., Selwyn, A. P. and Ganz, P. (1995) The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion. N. Engl. J. Med. 332, 488-493
26. 26 Sacks, F. M., Pfeffer, M. A., Moye, L. A. et al, for the Cholesterol And Recurrent Events Trial investigators. (1996) The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N. Engl. J. Med. 335, 1001-1009
27. 27 Wang, D. H. and Prewitt, R. L. (1990) Captopril reduces aortic and microvascular growth in hypertensive and normotensive rats. Hypertension 15, 68-77
28. 28 Vanbortel, L. M. A.B,. Kool, M. J. F. and Spek, J. J. (1995) Disparate effects of antihypertensive drugs on large artery distensibility and compliance in hypertension. J. Cardiovasc. Pharmacol. 26, 614-620
29. 29 Rakugi, H., Wang, D. S., Dzau, V. J. and Pratt, R. E. (1994) Potential importance of tissue angiotensin-converting enzyme inhibition in preventing neointima formation. Circulation 90, 449-455
30. 30 Horning, B. and Drexler, H. (1997) Endothelial function and bradykinin in humans. Drugs 54 (Suppl. 5), 42-47
31. 31 Zanzinger, J., Zheng, X. and Bassenge, E. (1994) Endothelium dependent vasomotor responses to endogenous agonists are potentiated following ACE inhibition by a bradykinin dependent mechanism. Cardiovasc. Res. 28, 209-214
32. 32 Berkenboom, G., Brekine, D., Unger, P., Grosfils, K., Staroukine, M. and Fontaine, J. (1995) Chronic angiotensin-converting enzyme inhibition and endothelial function of rat aorta. Hypertension 26, 738-743
33. 33 Pitt, B., Pepine, C., O'Neill, B., Haber, H., Pressler, M., Mancini, J. for the TREND investigators. (1997) Modulation of ACE inhibitor efficacy on coronary endothelial dysfunction by low-density lipoprotein cholesterol. J. Am. Coll. Cardiol. 29, 70A (Abstract)
34. 34 Cashin Hempell, L., Dinsmore, R. E., Chan, R. C. et al. for the QUIET investigators. (1997) LDL cholesterol and angiographic progression in the QUIET trial. J. Am. Coll. Cardiol. 29, 84A (Abstract)
35. 35 Diet, F., Pratt, R. E., Berry, G. J., Momose, N., Gibbons, G. H. and Dzau, V. J. (1996) Increased accumulation of tissue ACE in human atherosclerotic coronary artery disease. Circulation 94, 2756-2767
36. 36 Jeserich, M., Munzel, T., Hornig, B. et al. (1994) Improvement in vascular function by long-term angiotensin-converting enzyme inhibition in patients with chronic heart failure. Eur. Heart J. 15, P632 (Abstract)
37. 37 Gilligan, D. M., Badar, D. M., Panza, J. A., Quyyumi, A. A. and Cannon, R. O. (1994) Acute vascular effects of oestrogen in postmenopausal women. Circulation 90, 786-791
38. 38 Creager, M. A., Gallagher, S. J., Girerd, X. J., Coleman, S. M., Dzau, V. J. and Cooke, J. P. (1992) L-Arginine improves endothelium-dependent vasodilatation in hypercholesterolemic humans. J. Clin. Invest. 90, 1248-1253
39. 39 Casino, P. R., Kilcoyne, C. M., Quyyumi, A. A., Hoeg, J. M. and Panza, J. A. (1994) Investigation of decreased availability of nitric oxide precursor as the mechanism responsible for impaired endothelium-dependent vasodilatation in hypercholesterolemic patients. J. Am. Coll. Cardiol. 23, 844-850
40. 40 Gilligan, D. M., Guetta, V., Panza, J. A., Garcia, C. E., Quyyumi, A. A. and Cannon, R. O. (1994) Selective loss of microvascular endothelial dysfunction in human hypercholesterolemia. Circulation 90, 35-41
41. 41 Verbeuren, T. J., Jordaens, F. H., Zonnekeyn, L. L., Van Hove, C. E., Coene, M. C. and Herman, A. G. (1986) Effect of hypercholesterolemia on vascular reactivity in the rabbit. Circ. Res. 58, 552-564
42. 42 Mira, M. L., Silva, M. M., Queiroz, M. J. and Manso, C. F. (1993) Angiotensin converting enzyme inhibitors as oxygen free radical scavengers. Free Rad. Res. Commun. 19, 173-181
43. 43 Godfrey, E. G., Stewart, J., Dargie, H. J. et al. (1994) Effects of ACE inhibitors on oxidation of human low density lipoprotein. Br. J. Clin. Pharmacol. 37, 63-66
44. 44 Ohara, Y., Peterson, T. E. and Harrison, D. G. (1993) Hypercholesterolemia increases endothelial superoxide anion production. J. Clin. Invest. 91, 2546-2551
45. 45 Minor, Jr., R. L., Myers, P. R., Guerra, Jr., R., Bates, J. N. and Harrison, D. G. (1990) Diet-induced atherosclerosis increases the release of nitrogen oxides from rabbit aorta. J. Clin. Invest. 86, 2109-2116
46. 46 Simon, B. C., Haudenschild, C. C. and Cohen, R. A. (1993) Preservation of endothelium-dependent relaxation in atherosclerotic rabbit aorta by probucol. J. Cardiovasc. Pharmacol. 21, 893-901
47. 47 Azen, S. P., Qian, D., Mack, W. J. et al. (1996) Effect of supplementary antioxidant vitamin intake on carotid arterial wall intima-media thickness in a controlled clinical trial of cholesterol lowering. Circulation 94, 2369-2372